Chaccour, CarlosRabinovich, Regina2019-06-182019-06-182019-04-130140-6736https://hdl.handle.net/2445/135359There is ever-increasing anticipation for the potential of mass drug administration of endectocides (also known as systemic insecticides) to reduce malaria transmission, with ivermectin emerging as the most likely first-in-class endectocide.1 More than half of the 46 papers published on this subject in the past decade appeared in the past 2 years. 23 projects are registered in the MESA Track database, of which seven are active today; and, more importantly, trial mapping by the Malaria Ivermectin Roadmap2 shows that abundant new evidence on the topic will be available by 2020.2 p.application/pdfengcc by-nc-nd (c) Chaccour et al., 2019http://creativecommons.org/licenses/by-nc-nd/3.0/es/MalàriaParasitologia mèdicaMalariaMedical parasitologyinfo:eu-repo/semantics/article2019-05-27info:eu-repo/semantics/openAccess